In 2019, there were around two million deaths worldwide due to ischemic heart disease attributable to smoking. There were a further 6.5 million deaths from ischemic heart disease caused by other factors. This statistic shows the total number of smoking-attributable deaths from tobacco-related diseases worldwide in 2019.

In 2019, China was the country with the highest share of deaths among males due to tobacco use worldwide. At that time, around 35 percent of all deaths among males in China could be attributed to tobacco use. This statistic shows the countries with the highest percentage of male deaths due to tobacco use worldwide in 2019.

It is projected that the prevalence of tobacco smoking will be 15.4 percent by 2025, a decrease from a prevalence of 27 percent in the year 2000. This statistic depicts the prevalence of tobacco smoking worldwide from 2000 to 2020 and projections for 2025.

In 2018, there were more than 371 million cigarette smokers and 12. 6 million electronic cigarette users, with 340.2 million non-smokers exposed to secondhand smoke (SHS) in China, which resulted in heavy tobacco-attributable disease burden. According to the definition by the Global Burden of Disease Study 2017 (GBD 2017), tobacco is a level 2 risk factor that consists of three sublevel risk factors, namely, smoking, SHS, and chewing tobacco. In this study, we aimed to evaluate the trends in deaths and disability-adjusted life years (DALYs) attributable to tobacco, smoking, SHS, and chewing tobacco by sex in China from 1990 to 2017 and to explore the leading causes of tobacco-attributable deaths and DALYs using data from the GBD 2017. From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. From 1990 to 2017, the tobacco-attributable DALY rates decreased from 2209.11 (95% UI = 1678.63–2791.91) to 1489.05 (95% UI = 1237.65–1752.57) in females and increased from 5650.42 (95% UI = 5070.06–6264.39) to 6994.02 (95% UI = 6489.84–7558.41) in males. In 2017, the tobacco-attributable deaths in China were concentrated on chronic obstructive pulmonary disease, ischemic heart disease, lung cancer, and stroke. The focus of tobacco control for females was SHS in 1990, whereas smoking and SHS were equally important for tobacco control in females in 2017. Increasing tobacco taxes and prices may be the most effective and feasible measure to reduce tobacco-attributable disease burdens.

Cigarette consumption is a global issue, with millions of people around the world smoking tobacco products on a daily basis. Despite efforts to reduce smoking rates, it continues to be a significant health concern and a leading cause of preventable deaths. Find out more about worldwide cigarette consumption, key statistics, and the efforts being made to address this global problem.

In 2021, high blood pressure contributed to around 10.85 million deaths worldwide, while there were around 3.71 million deaths due to obesity.

In 2019, there were around 2.6 million deaths among men in the Western Pacific region that could be attributed to tobacco. This statistic illustrates the number of tobacco-attributable deaths in 2019 worldwide, by region and sex.

Daily cigarette consumption refers to the number of cigarettes a person smokes in a day. It is an important measure used to assess tobacco use and its associated health risks. The prevalence of daily cigarette consumption varies across countries and populations, influenced by factors such as social norms, cultural practices, availability of tobacco products, and government policies. Cigarette smoking is the leading cause of preventable deaths worldwide, responsible for millions of deaths each year due to va

Total population and smoking prevalence by gender and age groups in Nigeria (GATS 2012, Nigeria).

Tobacco consumption is a global problem that poses significant health risks to individuals and communities worldwide. Tobacco use kills more than 8 million people each year, with the majority of these deaths occurring in low- and middle-income countries. This article explores the factors influencing tobacco consumption, regional variations in prevalence, economic implications, tobacco control measures, and the need for a comprehensive approach to address this global epidemic.

In 2019, around 47 percent of tobacco-attributable deaths worldwide were in countries with a high Human Development Index, while countries with low HDI represented only about 2.7 percent of all tobacco-attributable deaths that year. This statistic illustrates the distribution of tobacco-attributable deaths worldwide in 2019, by HDI.

Tobacco consumption is a global health issue that has significant social, economic, and health implications. Here are some key statistics on tobacco consumption, including the number of tobacco users, the impact on global deaths, the economic costs, and efforts to reduce tobacco use.

There are more than one billion smokers globally according to the World Health Organization (WHO) report in 2017. Every year tobacco use causes nearly 6 million deaths worldwide. To deal with the smoking epidemic, society needs to invest resources efficiently. In this paper we introduce an optimal control model to determine the optimal mix of smoking initiation and cessation interventions to reduce smoking. We construct the model to reach a smoking prevalence target within a specific time horizon while minimizing cost. Our performance measure captures the cost of policy implementation over time, adjusting for inflation and social discounting. The analytical solutions to the model are presented in forms of ordinary differential equations (ODE). We then conduct several numerical simulations using data from the National Health Interview Survey (NHIS) and empirical studies. We first present analytical solutions for our model to solve for the optimal mix of smoking interventions. Then we simulate a public health policy to achieve 5% smoking prevalence in the US by 2030 using different combinations of real-life interventions. We examine the optimal trajectories, allocative efficiency and annual total cost of smoking cessation and initiation interventions. We find consistent results across all simulations. Our specific example reveals that the most efficient way to reach stated goal is by targeting cessation interventions first, and then gradually shifting resources to initiation interventions over time. While our numerical results are specific to the intervention we selected, our framework can be easily expanded to consider other potential interventions. We discuss the implications of our approach for the formulation of dynamic public health policies.

Years of life lost (YLLs) due to premature mortality, disability, and total DALYs.

According to Cognitive Market Research, the Global Heart Attack Diagnostics Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

The Heart Attack Diagnostics market will expand significantly by XX% CAGR between 2024 and 2031.
The non-invasive heart attack diagnostics type accounts for the largest market share and is anticipated to a healthy growth over the approaching years.
The Electrocardiogram Heart Attack Diagnostics holds the largest market share compared to others.
The usage of Heart Attack Diagnostics by hospitals & clinics as end-users holds the largest market share compared to others.
North-America region dominated the market and accounted for the highest revenue of XX% in 2022 and it is projected that it will grow at a CAGR of XX% in the future.

Factors Affecting the Heart Attack Diagnostics Market

The unhealthy lifestyles among people are raising heart attacks and related diseases.

The common sedentary lifestyle and poor nutrition are the main causes of heart attacks. It is revealed that youths who lead modern lifestyles are more likely to suffer from heart attacks. Poor food choices like fast food, processed foods, and sugary drinks are all increasing the risk of obesity, cholesterol, and other cardiovascular diseases. Researchers have revealed that being overweight or obese increases a person’s risk of coronary heart disease by up to 28%. (Source: https://www.imperial.ac.uk/news/181111/fat-increased-risk-heart-disease/#:~:text=Researchers%20have%20found%20that%20being,blood%20sugar%20and%20cholesterol%20levels.)

A lack of physical activity, loss of body workout, high tobacco consumption and smoking, high-stress levels, and inadequate healthcare can also lead to an increased risk of such disease. For instance, a new brief by World Health Organizations, the World Heart Federation, and the University of Newcastle Australia revealed that every year, nearly 1.9 million die from tobacco-induced heart disease. (Source:https://www.who.int/news/item/22-09-2020-tobacco-responsible-for-20-of-deaths-from-coronary-heart-disease#:~:text=Every%20year%2C%201.9%20million%20people,Day%2C%20marked%20on%2029%20September.)

This increased prevalence of heart-related cases is pushing people to consult healthcare services leading to the market growth of heart attack diagnostics.

The skill shortage in healthcare services can restrict the growth of the market.

Healthcare organizations face numerous challenges in the recruiting process compared to other industries. The process of attracting and selecting candidates with specific clinical, medical, and administrative skills is crucial and an ongoing battle, especially for positions like physicians, nurses, and specialist practitioners.

Furthermore, the rising portion of the healthcare workforce attaining retirement age, an older population seeking more healthcare services, and new technology shifting, altogether are leading to the shortage of skilled professions along with the rise in the need and demand for the same. The situation got worse when the global pandemic hit and stretched resources to the breaking point creating immense challenges for the service providers.

The Bureau of Labor Statistics (BLS) estimates that the U.S. will face a shortage of 195,400 nurses by 2031. The various reasons from people able to live longer to the unhealthy lifestyles of people leading to the rise in chronic disease, are increasing the need for medical professionals; however, the talent supply is unable to keep up with the demand limiting the growth of the market. (Source: https://www.peoplescout.com/insights/managing-skills-shortage-health-care/)

The increasing Research & Development projects to develop digital technology for improving heart health.

The need for technology-based solutions to enhance heart health is evident yet many people are still hesitant to accept and embrace these solutions due to issues like trust concerns, relevance, and ease of use. This gap creates an opportunity for the research community to present, validate, and create scalable, and engaging health-tech solutions to pursue them. To make it possible, various healthcare service providers, key players, and the government are continuously getting involved in investments and research to ...

Tobacco consumption refers to the use of tobacco products such as cigarettes, cigars, and smokeless tobacco. It is a widespread practice worldwide, with a long history dating back thousands of years. However, tobacco consumption has profound negative health effects and is a leading cause of preventable diseases and death globally. Learn more about the prevalence, health risks, and efforts to control tobacco consumption in this article.

Tobacco use is a leading cause of preventable deaths worldwide. Uganda enacted the Tobacco Control Act (TCA) 2015 to domesticate implementation of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) regulations. This study assessed the capacity to enforce the TCA and associated factors, as well as the level and barriers to its enforcement in Kampala, Uganda. A cross-sectional study using both quantitative and qualitative methods was employed. A structured questionnaire was used for quantitative data collection, and a WHO adapted capacity assessment open-ended guide was used for key informant interviews. Multivariable logistic regression was used to obtain odds ratios and 95% confidence intervals for the independent predictors for capacity to enforce the TCA. A total of 162 respondents from 5 institutions and six key informants were involved in the study. Findings established that only 23% (37/162) of the enforcers had the capacity to enforce the TCA. Male enforcers [OR = 0.16, 95% CI (0.05–0.55)], those who did not know when the law was enacted [OR = 0.19, 95% CI (0.07–0.52)], those with no plans to enforce the law [OR = 0.22, 95% CI (0.05–0.93)], and older enforcers (aged 31–40 years) [OR = 0.27, 95% CI (0.09–0.81)] were less likely to have the capacity to enforce the TCA. The level of enforcement of the TCA was mainly low to moderate for most of the institutions mandated to enforce it. Lack of knowledge about the law amongst the enforcers and general public, and inadequate funds were reported as major barriers to enforcement of the TCA. The capacity to enforce the TCA in Kampala was low. There is potential to enhance the capacity of enforcers through further dissemination of the Act, as well as sensitization of enforcers, institutional managers, and the general public about the legislation.

Cigarette consumption, the act of smoking tobacco-filled cigarettes, has serious health implications and is a leading cause of preventable diseases and premature deaths worldwide. This article explores the factors influencing cigarette consumption, the top consumer countries, and the efforts being made to reduce smoking rates.

In 2022, there were over 9.7 million cancer deaths worldwide. It is projected that the number of deaths due to cancer worldwide will increase to almost 18.5 million by 2050. The most prevalent type of cancer in 2022 was breast cancer with around 48 prevalent cases per 100,000 population. However, lung cancer is by far the deadliest type of cancer.

Lung Cancer Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. In 2022, around 1.82 million cancer deaths, or 19 percent of all cancer deaths worldwide were attributed to lung cancer. Long-term smoking is known to be a major cause of lung cancer. People who never quit smoking are 24 percent more likely to die before age 65 than people who never smoked in their lives.

Treatment In 2023, it was estimated that there were around 4,492 cancer immunotherapy products in R&D phases, as well as another 3,622 other cancer products in the R&D product pipeline. In the same year, it was projected that there were 965 active drugs for breast cancer, as well as 925 active drugs for non-small cell lung cancer.

Estimated direct medical costs (in ₦ as of March 2020).